NSC228155 is primarily utilized in cancer research due to its potential as an anticancer agent. It has been studied for its ability to inhibit the growth of various cancer cell lines, making it a candidate for further development in chemotherapy. Researchers are particularly interested in its mechanism of action, which involves targeting specific pathways involved in tumor proliferation and survival. Additionally, NSC228155 is being explored for its potential to enhance the efficacy of existing cancer treatments when used in combination therapies. Its role in preclinical studies highlights its significance in advancing oncology research and developing novel therapeutic strategies.